Results 51 to 60 of about 151,249 (259)

Neutrophils in Leprosy

open access: yesFrontiers in Immunology, 2019
Leprosy is an infectious disease caused by the intracellular bacillus Mycobacterium leprae that mainly affects the skin and peripheral nerves. One of the most intriguing aspects of leprosy is the diversity of its clinical forms.
Veronica Schmitz   +7 more
doaj   +1 more source

Skeletal Evidence for Leprosy in India by the Second Millenium B.C. [PDF]

open access: yes, 2009
Leprosy is a chronic infectious disease caused by _Mycobacterium leprae_ that affects almost 500,000 people worldwide^1^. The timing of first infection, geographic origin, and pattern of transmission of the disease are unknown^1-3^.
Gwendolyn Robbins   +6 more
core   +1 more source

Performance Assessment of Six Public Health Programs in Katsina State, Nigeria [PDF]

open access: yes, 2019
This research aimed to evaluate the performance of six ongoing public health programs through core performance indicators in Katsina State, Nigeria. The healthcare delivery in Africa is mostly program-based.
Bhalla, D. (Devender)   +2 more
core   +3 more sources

Lepromatous leprosy

open access: yesDermatology Online Journal, 2008
Lepromatous leprosy is a form of chronic granulomatous disease that is caused by infection with Mycobacterium leprae. Early involvement is marked by widespread, ill-defined, erythematous papules and plaques. With early intervention, leprosy is a curable disease; however, if not recognized and treated promptly, permanent sequelae and disability result ...
Mahlberg, Matthew J, Levis, William R
openaire   +4 more sources

The leprosy reaction is associated with salivary anti-Porphyromonas gingivalis IgA antibodies

open access: yesAMB Express, 2023
The aim of the study was to evaluate the association between salivary anti-Porphyromonas gingivalis IgA antibodies and the leprosy reaction. The levels of salivary anti - P.
Michelle Miranda Lopes Falcão   +14 more
doaj   +1 more source

Intrapartum leprosy [PDF]

open access: yesBaylor University Medical Center Proceedings, 2019
Leprosy is caused by an infection with Mycobacterium leprae, an acid-fast, slow-growing, obligate intracellular rod-shaped bacillus. Intrapartum leprosy most commonly occurs in the third trimester of pregnancy. This is likely due to pregnancy decreasing cellular immunity, thus allowing the organism to proliferate unchecked. This case report reviews the
Madeline Smoot   +3 more
openaire   +2 more sources

Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori   +2 more
wiley   +1 more source

Skin microbiota: a source of disease or defence?

open access: yes, 2008
Microbes found on the skin are usually regarded as pathogens, potential pathogens or innocuous symbiotic organisms. Advances in microbiology and immunology are revising our understanding of the molecular mechanisms of microbial virulence and the specific
Cogen, AL, Gallo, RL, Nizet, V
core   +1 more source

Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial

open access: yesTrials, 2018
Background The annual new-case detection rate for leprosy, while generally stable over the last decade, shows that transmission rates have remained stagnant despite the successful worldwide administration of multidrug therapy since the 1980s.
Daiane Santos dos Santos   +7 more
doaj   +1 more source

Combating the Stigmatization of Leprosy: How the first decade of The Star’s publication made the case for romantic relationships and the preservation of domestic life in the Carville Leprosarium [PDF]

open access: yes, 2013
The stigmatization of leprosy has long been acknowledged as one of the primary obstacles to not only effectively treating leprous patients on a physical level, but also achieving their integration and acceptance into society.
Reed, Gabriela
core   +1 more source

Home - About - Disclaimer - Privacy